Regulatory

Latest News

Image credit: crevis | stock.adobe.com
Wearable Device for Osteopenia in Postmenopausal Women Granted FDA Clearance

January 24th 2024

Osteoboost is the first non-pharmacological therapy approved to treat low bone density in postmenopausal women.

Image credit: Saiful52 | stock.adobe.com
FDA Accepts BLA for Novel Positron Emission Tomography Imaging Agent for Renal Cell Carcinoma

January 5th 2024

FDA Awards Breakthrough Device Designation to Roche's Neurofilament Light Chain Test for MS
FDA Awards Breakthrough Device Designation to Roche's Neurofilament Light Chain Test for MS

November 9th 2023

stock.adobe.com
FDA Releases Draft Guidance for Regulatory Considerations for Prescription Drug-Use-Related Software

September 26th 2023

stock.adobe.com
FDA Clears Zeta Surgical’s Mixed Reality Navigation System

September 11th 2023

Latest CME Events & Activities

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Cases and Conversations™: Evidence-Based Approaches to Management of CKD in Your Patients with T2DM

September 25, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.